Viridian Therapeutics Ownership | Who Owns Viridian Therapeutics?

Overview Forecast RevenueFinancials Chart

Viridian Therapeutics Ownership Summary

Viridian Therapeutics is owned by 112.95% institutional investors, 0.14% insiders. Fmr is the largest institutional shareholder, holding 15.01% of VRDN shares. Fidelity Select Health Care is the top mutual fund, with 3.28% of its assets in Viridian Therapeutics shares.

VRDN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Viridian Therapeutics	112.95%	0.14%	-13.08%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	12.25M	15.01%	$264.34M
Blackrock	4.77M	7.81%	$62.10M
Blackrock funding, inc. /de	5.43M	6.65%	$117.15M
Deep track capital, lp	5.38M	6.59%	$116.11M
Kynam capital management, lp	4.43M	5.43%	$95.55M
Vanguard group	4.33M	5.31%	$93.48M
Vr adviser	3.88M	4.76%	$83.79M
Fairmount funds management	3.46M	4.24%	$74.66M
Commodore capital lp	3.20M	3.92%	$69.06M
Tang capital management	2.84M	3.48%	$61.35M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Kynam capital management, lp	4.43M	7.11%	$95.55M
Fairmount funds management	3.46M	6.72%	$74.66M
5am venture management	736.60K	5.82%	$15.90M
Vr adviser	3.88M	4.72%	$83.79M
Rosalind advisors	600.00K	4.43%	$12.95M
Commodore capital lp	3.20M	3.37%	$69.06M
Novo	2.38M	3.31%	$51.36M
Deep track capital, lp	5.38M	3.24%	$116.11M
Eversept partners, lp	1.92M	2.86%	$41.53M
Kopp family office	193.83K	2.72%	$4.18M

Top Buyers

Holder	Shares	% Assets	Change
Perceptive advisors	1.46M	0.91%	1.01M
Blackrock	4.77M	0.00%	960.99K
Wellington management group llp	1.12M	0.00%	851.99K
Fisher asset management	1.20M	0.01%	691.27K
Deutsche bank ag\	937.47K	0.01%	550.53K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-1.96M
Commodore capital lp	3.20M	3.37%	-1.68M
Polar capital	-	-	-889.20K
Great point partners	-	-	-750.00K
Logos global management lp	-	-	-700.00K

New Positions

Holder	Shares	% Assets	Change	Value
Silverarc capital management	259.51K	0.76%	259.51K	$5.60M
Propel bio management	90.00K	1.94%	90.00K	$1.94M
Simplify asset management	50.00K	0.02%	50.00K	$1.08M
Campbell & co investment adviser	26.32K	0.04%	26.32K	$567.88K
Exoduspoint capital management, lp	14.41K	0.00%	14.41K	$311.03K

Sold Out

Holder	Change
True wealth design	-4.00
Nelson, van denburg & campbell wealth management group	-8.00
Creative financial designs inc /adv	-10.00
Game plan financial advisors	-13.00
Td private client wealth	-18.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	172	-1.15%	92,157,310	-2.54%	112	0.84%	68	-21.84%	65	1.56%
Jun 30, 2025	174	-1.69%	94,556,349	8.58%	115	1.01%	87	-6.45%	64	16.36%
Mar 31, 2025	179	-6.28%	91,344,327	0.33%	112	0.60%	92	-24.59%	55	34.15%
Dec 31, 2024	186	6.29%	85,180,374	-2.05%	128	0.75%	118	7.27%	40	-4.76%
Sep 30, 2024	173	18.49%	86,676,793	24.72%	130	1.01%	111	24.72%	40	37.93%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Select Health Care	2.68M	3.28%	52.20K
Vanguard US Total Market Shares ETF	2.24M	2.75%	324.50K
Vanguard Total Stock Mkt Idx Inv	2.24M	2.74%	-49.64K
Fidelity Advisor Biotechnology I	1.76M	2.15%	12.00K
iShares Russell 2000 ETF	1.67M	2.05%	-
Fidelity Advisor Health Care I	1.57M	1.92%	29.70K
US Small-Cap Growth II Equity Comp	1.21M	1.48%	237.23K
T. Rowe Price New Horizons	1.16M	1.42%	-47.96K
Fidelity Small Cap Growth	1.05M	1.29%	-
FIAM Small Cap Core Composite	1.01M	1.24%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 23, 2025	Fairmount Funds Management LLC		Buy	$10.00M
Sep 27, 2024	Beetham Thomas W.	Chief Operating Officer	Buy	$117.05K
Sep 27, 2024	Mahoney Stephen F.	President and CEO	Buy	$499.26K
Sep 13, 2024	Fairmount Funds Management LLC		Buy	$30.00M
Jan 22, 2024	Fairmount Funds Management LLC	See Remarks	Buy	$10.00M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	3	-
2024 Q2	-	-

VRDN Ownership FAQ

Who Owns Viridian Therapeutics?

Viridian Therapeutics shareholders are primarily institutional investors at 112.95%, followed by 0.14% insiders and -13.09% retail investors. The average institutional ownership in Viridian Therapeutics's industry, Biotech Stocks , is 45.22%, which Viridian Therapeutics exceeds.

Who owns the most shares of Viridian Therapeutics?

Viridian Therapeutics’s largest shareholders are Fmr (12.25M shares, 15.01%), Blackrock (4.77M shares, 7.81%), and Blackrock funding, inc. /de (5.43M shares, 6.65%). Together, they hold 29.48% of Viridian Therapeutics’s total shares outstanding.

Does Blackrock own Viridian Therapeutics?

Yes, BlackRock owns 7.81% of Viridian Therapeutics, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 62.1M$. In the last quarter, BlackRock increased its holdings by 960.99K shares, a 25.21% change.

Who is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested?

Kynam capital management, lp is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.11% of its assets in 4.43M Viridian Therapeutics shares, valued at 95.55M$.

Who is the top mutual fund holder of Viridian Therapeutics shares?

Fidelity Select Health Care is the top mutual fund holder of Viridian Therapeutics shares, with 3.28% of its total shares outstanding invested in 2.68M Viridian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools